Dr. Vitolo brings more than 20 years of experience in neuroscience research and drug development. At Cerevance, he leads the global clinical development and regulatory operations.
Dr. Vitolo most recently served as chief medical officer and global head of R&D at Alcyone Therapeutics. Prior to this position, Dr. Vitolo served as senior vice president, head of R&D and chief medical officer at Relmada Therapeutics Inc. While at Relmada, he critically contributed to the company’s growth and strategy, including leading the successful initiation and completion of dextromethadone clinical studies.
Earlier in his career, Dr. Vitolo was vice president of clinical development at Homology Medicines and held positions of increasing responsibilities at Pfizer, including senior director and head of neuromuscular clinical research, research project lead, global clinical lead and medical director in the neuroscience research unit.
Dr. Vitolo is a trained and practicing neuropsychiatrist. After receiving his medical degree from the University of Rome La Sapienza, he completed his psychiatry residency at Washington University in St. Louis and completed a fellowship in behavioral neurology and neuropsychiatry at Brigham and Women’s Hospital and Massachusetts General Hospital. Dr. Vitolo also has a Master of Medical Sciences degree from Harvard Medical School.